Bloodborne viral hepatitis infections among drug users: the role of vaccination.

Int J Environ Res Public Health

Department of Internal Medicine, Medical Unit for Addictive Disorders, Policlinico GB Rossi, Verona, Italy.

Published: January 2009

Drug use is a prevalent world-wide phenomenon and hepatitis virus infections are traditionally a major health problem among drug users (DUs). HBV and HCV, and to a lesser extent HAV, are easily transmitted through exposure to infected blood and body fluids. Viral hepatitis is not inevitable for DUs. Licensed vaccines are available for hepatitis A and hepatitis B. The purpose of this overview is to show some epidemiological data about HBV and the other blood-borne viral hepatitis among DUs and to summarize and discuss use of hepatitis vaccinations in this population. Successful vaccination campaigns among DUs are feasible and well described. We try to focus on the most significant results achieved in successful vaccination programs as reported in scientific literature. Vaccination campaigns among DUs represent a highly effective form of health education and they are cost-saving.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672321PMC
http://dx.doi.org/10.3390/ijerph6010400DOI Listing

Publication Analysis

Top Keywords

viral hepatitis
12
drug users
8
successful vaccination
8
vaccination campaigns
8
campaigns dus
8
hepatitis
7
dus
5
bloodborne viral
4
hepatitis infections
4
infections drug
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!